Agilent Technologies (A) EBITDA Margin (2010 - 2026)
Agilent Technologies (A) posted quarterly EBITDA Margin of 21.74% for Q2 2026, up 376.0% year-over-year from 4.57% in Q2 2025, and up 10.75% quarter-over-quarter from 19.63% in Q1 2026.
Agilent Technologies (A) EBITDA Margin (2010 - 2026) Analysis & Trends
Agilent Technologies (A) has reported EBITDA Margin for 17 consecutive years, with 21.74% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin rose 376.0% year-over-year to 21.74%; the TTM figure through Apr 2026 stood at 21.5% (up 12.0% YoY), while the FY2025 annual figure was 21.29%, down 157.0% from the prior year.
- EBITDA Margin grew to 21.74% in Q2 2026 per A's latest filing, from 19.63% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.47% in Q4 2022 and bottomed at 7.95% in Q3 2023.
- Historically, EBITDA Margin has averaged 21.7% across 5 years, with a median of 22.43% in 2022.
- Annual changes were most pronounced in 2023 — EBITDA Margin plunged 1597 bps — and 2024, when it jumped 1315 bps.
- Agilent Technologies' EBITDA Margin stood at 25.47% in 2022, then declined by 5 bps to 24.17% in 2023, then fell by 1 bps to 23.99% in 2024, then slipped by 1 bps to 23.8% in 2025, then fell by 9 bps to 21.74% in 2026.
- Business Quant data shows A's EBITDA Margin at 21.74% in Q2 2026, 19.63% in Q1 2026, and 23.8% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 15.08% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 10.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 21.74% |
| Jan 31, 2026 | 19.63% |
| Oct 31, 2025 | 23.80% |
| Jul 31, 2025 | 20.71% |
| Apr 30, 2025 | 17.99% |
| Jan 31, 2025 | 22.37% |
| Oct 31, 2024 | 23.99% |
| Jul 31, 2024 | 21.10% |
| Apr 30, 2024 | 23.08% |
| Jan 31, 2024 | 23.16% |
| Oct 31, 2023 | 24.17% |
| Jul 31, 2023 | 7.95% |
| Apr 30, 2023 | 22.31% |
| Jan 31, 2023 | 24.26% |
| Oct 31, 2022 | 25.47% |
| Jul 31, 2022 | 23.92% |
| Apr 30, 2022 | 22.40% |
| Jan 31, 2022 | 22.46% |
| Oct 31, 2021 | 23.80% |
| Jul 31, 2021 | 21.19% |